FI924744A0 - Terapeutiska aemnen - Google Patents
Terapeutiska aemnenInfo
- Publication number
- FI924744A0 FI924744A0 FI924744A FI924744A FI924744A0 FI 924744 A0 FI924744 A0 FI 924744A0 FI 924744 A FI924744 A FI 924744A FI 924744 A FI924744 A FI 924744A FI 924744 A0 FI924744 A0 FI 924744A0
- Authority
- FI
- Finland
- Prior art keywords
- aemnen
- therapeutic
- compound
- acridinedione
- cyanophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919122305A GB9122305D0 (en) | 1991-10-21 | 1991-10-21 | Therapeutic agents |
| GB929213538A GB9213538D0 (en) | 1992-06-25 | 1992-06-25 | Therapeutic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI924744A0 true FI924744A0 (fi) | 1992-10-20 |
| FI924744A FI924744A (fi) | 1993-04-22 |
Family
ID=26299722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI924744A FI924744A (fi) | 1991-10-21 | 1992-10-20 | Terapeutiska aemnen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5258390A (fi) |
| EP (1) | EP0539153B1 (fi) |
| JP (1) | JP3157924B2 (fi) |
| KR (1) | KR930007907A (fi) |
| AT (1) | ATE152103T1 (fi) |
| AU (1) | AU659500B2 (fi) |
| CA (1) | CA2080950A1 (fi) |
| CZ (1) | CZ317592A3 (fi) |
| DE (2) | DE69223736T2 (fi) |
| FI (1) | FI924744A (fi) |
| GB (1) | GB9220570D0 (fi) |
| HU (1) | HUT65626A (fi) |
| IL (1) | IL103478A0 (fi) |
| MY (1) | MY106661A (fi) |
| NO (1) | NO178696C (fi) |
| NZ (1) | NZ244822A (fi) |
| PL (1) | PL169716B1 (fi) |
| TW (1) | TW223061B (fi) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
| EP0539154B1 (en) | 1991-10-21 | 1997-12-29 | Zeneca Limited | Acridine-1,8-dione-derivatives as therapeutic agents |
| US5455253A (en) * | 1992-10-20 | 1995-10-03 | Zeneca Limited | Heterocyclic derivatives |
| GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
| GB9310069D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Heterocyclic compounds |
| GB9407432D0 (en) * | 1994-04-14 | 1994-06-08 | Zeneca Ltd | Heterocyclic derivative |
| JP3348230B2 (ja) | 1995-03-03 | 2002-11-20 | アルゴス ファーマシューティカル コーポレーション | 尿失禁の治療用のデキシトルメトルファン又はデキシトルオルファンの使用 |
| GB9707695D0 (en) * | 1996-08-07 | 1997-06-04 | Hoffmann La Roche | Tricyclic dione derivatives |
| US7030096B1 (en) * | 1997-02-13 | 2006-04-18 | Albert Einstein College Of Medicine Of Yeshiva University | Method of enhancing relaxation of penile smooth muscle by introduction of DNA encoding maxi-K potassium channel protein |
| US6191140B1 (en) | 1998-10-28 | 2001-02-20 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| US6642222B2 (en) | 1998-10-28 | 2003-11-04 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| CA2348165A1 (en) * | 1998-10-28 | 2000-05-04 | Abbott Laboratories | Dihydropyridine compounds and methods of use |
| US6518279B2 (en) | 1999-03-04 | 2003-02-11 | Abbott Laboratories | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| US6348486B1 (en) * | 2000-10-17 | 2002-02-19 | American Home Products Corporation | Methods for modulating bladder function |
| AU2002338333A1 (en) | 2001-04-04 | 2002-10-21 | Wyeth | Methods for treating hyperactive gastric motility |
| EP1688141A1 (en) | 2005-01-31 | 2006-08-09 | elbion AG | The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
| US8439867B2 (en) | 2005-06-07 | 2013-05-14 | David R. Staskin | Injection guidance system and method |
| ATE451359T1 (de) * | 2006-02-10 | 2009-12-15 | Janssen Pharmaceutica Nv | Neue tricyclische dihydropyrazine als kaliumkanalöffner |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3454577A (en) * | 1965-11-09 | 1969-07-08 | Hoffmann La Roche | 4-(1,2,3,4,5,6,7,8 - octahydro - 1,8 - dioxo-9-acridanyl) - benzenesulfonamide and derivatives |
| DE2003148A1 (de) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
| DE2018738A1 (en) * | 1970-04-18 | 1971-10-28 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Hydrogenated pyridines, quinolines andacridi |
| US4021434A (en) * | 1972-01-22 | 1977-05-03 | Yamanouchi Pharmaceutical Co., Ltd. | Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate |
| DE2242106A1 (de) * | 1972-08-26 | 1974-03-21 | Agfa Gevaert Ag | Lichtempfindliches photographisches material |
| DE2718130C2 (de) * | 1977-04-23 | 1979-05-17 | Du Pont De Nemours (Deutschland) Gmbh, 4000 Duesseldorf | lichtempfindliches Aufzeichnungsmaterial |
| US4546186A (en) * | 1983-12-14 | 1985-10-08 | American Home Products Corporation | 1,4,5,6,7,8-Hexahydro-2-methyl-5-oxo-4-(2-thiazolyl)-3-quinoline carboxylic acid 2-methyl(phenylmethyl)amino ethyl ester and pharmaceutically acceptable salts |
-
1992
- 1992-09-30 GB GB929220570A patent/GB9220570D0/en active Pending
- 1992-10-20 DE DE69223736T patent/DE69223736T2/de not_active Expired - Fee Related
- 1992-10-20 AU AU27139/92A patent/AU659500B2/en not_active Ceased
- 1992-10-20 NZ NZ244822A patent/NZ244822A/en unknown
- 1992-10-20 HU HU9203288A patent/HUT65626A/hu unknown
- 1992-10-20 CA CA002080950A patent/CA2080950A1/en not_active Abandoned
- 1992-10-20 AT AT92309566T patent/ATE152103T1/de not_active IP Right Cessation
- 1992-10-20 NO NO924066A patent/NO178696C/no unknown
- 1992-10-20 EP EP92309566A patent/EP0539153B1/en not_active Expired - Lifetime
- 1992-10-20 DE DE69219271T patent/DE69219271T2/de not_active Expired - Fee Related
- 1992-10-20 KR KR1019920019226A patent/KR930007907A/ko not_active Application Discontinuation
- 1992-10-20 CZ CS923175A patent/CZ317592A3/cs unknown
- 1992-10-20 IL IL92103478A patent/IL103478A0/xx unknown
- 1992-10-20 TW TW081108329A patent/TW223061B/zh active
- 1992-10-20 FI FI924744A patent/FI924744A/fi not_active Application Discontinuation
- 1992-10-20 US US07/963,798 patent/US5258390A/en not_active Expired - Lifetime
- 1992-10-20 JP JP28186292A patent/JP3157924B2/ja not_active Expired - Fee Related
- 1992-10-20 PL PL92296229A patent/PL169716B1/pl unknown
- 1992-10-20 MY MYPI92001895A patent/MY106661A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2080950A1 (en) | 1993-04-22 |
| DE69219271D1 (de) | 1997-05-28 |
| HU9203288D0 (en) | 1992-12-28 |
| AU659500B2 (en) | 1995-05-18 |
| NO178696B (no) | 1996-02-05 |
| PL169716B1 (pl) | 1996-08-30 |
| KR930007907A (ko) | 1993-05-20 |
| EP0539153A1 (en) | 1993-04-28 |
| AU2713992A (en) | 1993-04-22 |
| DE69219271T2 (de) | 1997-08-07 |
| ATE152103T1 (de) | 1997-05-15 |
| CZ317592A3 (en) | 1993-05-12 |
| HUT65626A (en) | 1994-07-28 |
| JPH05201986A (ja) | 1993-08-10 |
| IL103478A0 (en) | 1993-03-15 |
| NO924066L (no) | 1993-04-22 |
| FI924744A (fi) | 1993-04-22 |
| NO924066D0 (no) | 1992-10-20 |
| MY106661A (en) | 1995-07-31 |
| EP0539153B1 (en) | 1997-04-23 |
| DE69223736T2 (de) | 1998-05-07 |
| PL296229A1 (en) | 1993-10-04 |
| US5258390A (en) | 1993-11-02 |
| JP3157924B2 (ja) | 2001-04-23 |
| GB9220570D0 (en) | 1992-11-11 |
| NZ244822A (en) | 1994-10-26 |
| NO178696C (no) | 1996-05-15 |
| DE69223736D1 (de) | 1998-02-05 |
| TW223061B (en) | 1994-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI924744A0 (fi) | Terapeutiska aemnen | |
| TW273550B (fi) | ||
| MY103352A (en) | Piperazinyl-heterocyclic compounds | |
| CA2263561A1 (en) | Thienopyrimidines | |
| GR3026218T3 (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid | |
| ES2084944T3 (es) | Amidas terapeuticas. | |
| ATE248837T1 (de) | Chinuclidin-acrylamide | |
| NZ247201A (en) | Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions | |
| DK0501705T3 (da) | Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje | |
| ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
| MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
| DE59506374D1 (de) | Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel | |
| HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
| EP0535250A4 (en) | Novel compounds and use thereof as medicine | |
| ZA933455B (en) | Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
| MX9205778A (es) | Agente terapeutico. | |
| RU92004356A (ru) | Производные 1,8-акридиндиона, полезные как терапевтическое средство для лечения недержания мочи, и способ его получения | |
| ITMI911930A1 (it) | Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |